Aptyx

Molded Devices, Inc. specializes in custom plastic injection molding and contract manufacturing, serving industries such as medical, industrial, and aerospace. The company is known for its advanced production technologies and quality-driven approach. Founded in 1998 in Tempe, US, Molded Devices, Inc.

is engaged in custom plastic injection molding and contract manufacturing. The company was acquired by TruArc Partners from PNC Mezzanine Capital in August 2022, which will support its growth initiatives. Brian Anderson founded the company, and currently, Gregg Tobin serves as the CEO. Molded Devices, Inc.

(MDI) specializes in custom plastic injection molding and contract manufacturing services tailored to various industries, including medical, industrial, and aerospace sectors. Their core offerings encompass a range of products such as medical devices like catheters, cannulas, and airway management devices, as well as components for industrial applications, including specialized gears and assemblies. MDI employs advanced technologies such as ultrasonic welding, blow molding, and clean room molding to ensure high-quality standards in production. The company serves a diverse clientele that includes major OEMs and medical device manufacturers across global markets, including North America, Europe, and Asia.

By integrating extensive engineering and design capabilities with robust manufacturing solutions, MDI addresses complex supply chain challenges and optimizes product development from conception through to production. MDI operates on a B2B transaction model primarily focused on partnerships with OEMs and medical device companies. Revenue is generated through tailored contracts for manufacturing services that include product design, molding, assembly, and packaging, with a commitment to meeting clients' specific requirements for timelines and quality. The company has established various pricing structures based on project scope, production scale, and complexity of the products involved.

Flagship offerings, such as medical devices and custom molded components, are integral to MDI's revenue streams, facilitating long-term relationships with clients. Each transaction typically involves detailed negotiations to align production capabilities with customer specifications, ultimately resulting in contracts that reflect the unique needs of their diverse client base. Following the acquisition in August 2022, Molded Devices, Inc. is set to leverage new resources for its growth.

The company is focusing on expanding its product offerings in the medical device sector and aims to enter new markets in Europe and Asia by 2024. Recent funding will facilitate these initiatives, supporting the development of innovative product lines and enhancing manufacturing capabilities to meet evolving client demands.